Aslan R, Sevin B, Dernek S, Manti Z
Anadolu University, Faculty of Medicine, Cardiovascular Surgery Department, Eskişehir, Turkey.
J Cardiovasc Surg (Torino). 1992 Mar-Apr;33(2):154-9.
We have used umbilical veins as experimental graft materials for superior vena cava replacement. The patency rate of these grafts in 25 laboratory animals was 96%; the mortality and graft thrombosis rate was 4%. Histopathologically, no evidence of rejection was detected in the graft material. These results suggest that umbilical veins are superior to other prosthetic materials as grafts in venous surgery.
我们已将脐静脉用作上腔静脉置换的实验性移植材料。在25只实验动物中，这些移植血管的通畅率为96%；死亡率和移植血管血栓形成率为4%。组织病理学检查未在移植材料中发现排斥反应的证据。这些结果表明，在静脉手术中，脐静脉作为移植材料优于其他人工材料。
